What does Liquet Medical do?
Liquet Medical is a clinical-stage medical device company that develops catheter-based technologies for real-time monitoring of hemodynamic responses in the pulmonary vasculature. Its flagship product, the Versus Catheter, facilitates controlled infusion of fluids and continuous pressure monitoring.
How much did they raise?
The company closed its Seed funding round in May 2025 with an undisclosed amount, and while lead and participant investors were not detailed, the funding initiative was led by CEO John Schindler.
What are their plans for the money?
Liquet Medical plans to use the funds to support an upcoming pilot study that evaluates the device's ability to monitor hemodynamic responses during localized drug delivery. This could improve treatment protocols for managing pulmonary embolism by allowing personalized adjustments in real time.
What have they achieved so far?
A notable achievement for Liquet Medical is the FDA 510(k) clearance of its Versus Catheter, underscoring the device's potential in advancing pulmonary therapy and hemodynamic monitoring.
